Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 7, 2025 · Filed Nov 12, 2025
A board member of Aflac sold $114K of Aflac shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$114,000
Shares × reported transaction price
3 days after results of Nov 4, 2025, 89 days before results of Feb 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $114.09 on Nov 7, 2025, within 1% of its 52-week high, after a 2% rise over the previous 30 trading days
52-week range $98.09 (Aug 1, 2025) to $114.10 (Nov 27, 2024), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $111.36 on Sep 26, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.9% | -2.9% | -1.0% |
| 30 days | -3.0% | +1.3% | -4.3% |
| 90 days | +1.1% | +3.0% | -1.9% |
| 180 days | +1.0% | +9.8% | -8.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
The money chief of Aflac sold $377K of Aflac shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.